Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades

Cited by (124)

Items 101–124 of 124

1. Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis
   Rolf Grempler, Jennifer Ahlberg, Eva Germovsek, Priyanka Gupta, Hua Li, Minu Pilvankar, Ashish Sharma, Peter Stopfer, Steven B. Hansel · 2023 · Advances in Therapy
2. Pampa Dissolution：An Alternative Method for Oral NDA Formulation Development
   Joe Chou, Roger Lai, Jason Chou, Shelly Fu, Wei-Hsuan Wang · 2024 · Research Journal of Pharmaceutical Dosage Forms and Technology
3. In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
   Israa Mohamed Shamkh, Dina Setiana Pratiwi, Hanaa S. Omar, Nour El‐Houda A. Reyad · 2021 · Journal of Molecular Docking
4. Tools to enable animal to human translation
   Guilherme S. Ferreira · 2020
5. Synthesis and Anti-Inflammatory Activity of Novel 2-Amino-4,5,6,7- Tetrahydrobenzo[B]Thiophene-Derived NRF2 Activators
   Kit‐Kay Mak, Zhang Shiming, Ola Epemolu, Albena T. Dinkova‐Kostova, Geoffrey Wells, Irina G. Gazaryan, Raghavendra Sakirolla, Mohd Zulkefeli, Mallikarjuna Rao Pichika · 2022 · SSRN Electronic Journal
6. Leveraging ADME/PK information to enable knowledge-driven decisions in drug discovery and development
   Larry C. Wienkers · 2023 · Elsevier eBooks
7. Predicting unpredictable human pharmacokinetics: case studies from the trenches of drug discovery
   Zheng Yang · 2023 · Elsevier eBooks
8. Book Review: Drug Disposition and Pharmacokinetics: Principles and Applications for Medicine, Toxicology and Biotechnology
   Leanne L. Bedard · 2023 · International Journal of Toxicology
9. Oral NDA Research from AI Prediction to Clinical Drug Formulation
   Joe Chou, Roger Lai, Jason Chou, Shelly Fu, Benjamin Chang · 2024 · Research Journal of Pharmaceutical Dosage Forms and Technology
10. The Road from Laboratory to Patient
    Yongchang Zhang, Yangqian Chen · 2024 · Springer eBooks
11. Efficiency in Medicinal Chemistry via Computational Chemistry
    Manojkumar Rajapriyan, A. Meera Moydeen, M. Syed Ali Padusha · 2025 · IGI Global eBooks
12. Multiobjective optimization of biological and physical properties in drug discovery
    M. Paul Gleeson, Dino Montanari · 2025 · Elsevier eBooks
13. Resources for Accelerating Medicine Discovery
    Maria Cristina Garcia‐Paredes, Pushkar G. Ghanekar, Rachel K. Chambers, Anne‐Marie Dechert Schmitt, Katie L. Cavanagh, Eric M. Woerly · 2025 · Wiley eBooks
14. Half-life prediction of central nervous system (CNS) small molecules in humans using gradient tree boosting
    Hong Wang, Pan Zhang, Stephen J. Barigye, James R. Empfield, Steven S. Wesolowski · 2025 · Future Medicinal Chemistry
15. Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights
    Maryam Soliman, Noha S. Mostafa, Sally Tarek Mahmoud, Dalia S. El‐Gamil, Mohammad Abdel‐Halim, Marwa Mohammed Fouad · 2025 · Journal of Chromatography B
16. Modeling ADME/Tox for Drug Discovery in the Age of Data
    Natália Aniceto, Alex A. Freitas, Taravat Ghafourian · 2025 · Springer handbooks
17. Gaps and paths forward in cancer pharmacology and translational research
    Elizabeth Hughes, Lindsay L Davenport, Christopher Zdyrski, Aleksandra Pawlak, Jonathan Paul Mochel, Eugene F. Douglass · 2026 · Frontiers in Pharmacology
18. Discovery of Potent 1,3-Cyclobutane-Containing Dual A 2A /A 2B Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer
    Zachary G. Brill, Alec H. Christian, Lorena Rico, Sebastian E. Schneider, Eric M. Phillips, Matthew S. Winston, Harini Krishnamurthy, Elisabeth T. Hennessy, Umar Faruk Mansoor, Dong Xiao et al. · 2026 · ACS Medicinal Chemistry Letters
19. Enabling AI to Drive Innovation and Precision across Oncology R&D
    Richard J. A. Goodwin, Simon T. Barry, James Weatherall, Stefan J. Platz, Jorge Sergio Reis-Filho · 2026 · Cancer Discovery
20. Computational discovery of emodin-based anthraquinones as PARP-1 inhibitors with relevance to ovarian and prostate cancer
    Sohag Ahmed, Md Mohi Uddin, Subrato Das, Abdulla All Maruf, Ahmed Nasim, Monotosh Kumar Sarkar, Shu Shanta, Rubel Hossain, Subash Chandra Shaha, Chinmoy Kumar Saha et al. · 2026 · Scientific Reports
21. Emerging Research on Marine Polyphenols. Unique Properties, Health Benefits, and Future Research Direction
    Viswapriya Viswalingam, Dileep Kumar · 2026 · Springer eBooks
22. Strategic Substitutions of Agmatine Reduce Tactile Hypersensitivity in Peripheral Nerve Injury
    Cristina D. Peterson, Tongzhen Xie, Christina M. Larson, Cecilia Barajas, Lukas D. Caye, Benjamin M. Clements, Kelsey R. Pflepsen, Kelley F. Kitto, Sudhakar Jakkaraj, Eyup Akgün et al. · 2026 · Journal of Pharmacology and Experimental Therapeutics
23. BindingDB Entry 50018072: Overcoming Preclinical Safety Obstacles to Discover (
    BindingDB · 2023 · UC San Diego
24. BindingDB Entry 50019633: Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector.
    BindingDB · 2024 · UC San Diego